DEBRA REMLEY: Open Payments
NPI 1548592249 · MONROE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 64 payments from 12 companies in 2025. Trend: 2023 $614 · 2024 $588 · 2025 $1,363
Food & beverage: $1,363
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $356 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $185 |
| ABBVIE INC. | 10 | $166 |
| E.R. Squibb & Sons, L.L.C. | 11 | $153 |
| Otsuka America Pharmaceutical, Inc. | 6 | $139 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Alkermes, Inc. | 3 | $68 |
| Sage Therapeutics, LLC | 3 | $64 |
| Neurocrine BioSciences, Inc. | 2 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
Products named: HETLIOZ, CAPLYTA, VRAYLAR, COBENFY, ABILIFY MAINTENA, Auvelity, ARISTADA, FANAPT.
Industry payments across MI — which companies pay providers there.
